SBFM
Sunshine Biopharma Inc.
Key Financials
Gross Profit
$12.3M
↑ 14.9%
Operating Income
$-6227029
↓ 7.1%
EPS (Diluted)
$-7.32
↓ 3752.6%
Revenue
$36.3M
↑ 4.1%
Net Income
$-5975352
↓ 16.4%
Shareholders' Equity
$23.0M
↓ 2.0%
Cash & Equivalents
$21.8M
↑ 967.2%
Total Liabilities
$7.0M
↓ 0.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1 | 10/2/2026 | View on SEC |
| DEF 14C | 9/28/2026 | View on SEC |
| DRS | 9/24/2026 | View on SEC |
| PRE 14C | 9/16/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 8-K | 9/11/2026 | View on SEC |
| EFFECT | 9/8/2026 | View on SEC |
| 424B3 | 9/8/2026 | View on SEC |
| S-1 | 8/28/2026 | View on SEC |
| 8-K | 8/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SBFM |
| Company Name | Sunshine Biopharma Inc. |
| CIK | 1402328 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | CO |
| Phone | 954-330-0684 |